切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2023, Vol. 10 ›› Issue (04) : 267 -270. doi: 10.3877/cma.j.issn.2095-7157.2023.04.007

综述

肠系膜脂膜炎临床诊治的研究进展
周晓晴, 宁波, 令狐恩强()   
  1. 100853 北京,解放军总医院第一医学中心消化内科医学部;300071 天津,南开大学医学院
    100853 北京,解放军总医院第一医学中心消化内科医学部
  • 收稿日期:2023-07-11 出版日期:2023-11-15
  • 通信作者: 令狐恩强

Research progress in diagnosis and treatment of mesenteric panniculitis

Xiaoqing Zhou, Bo Ning, Enqiang Linghu()   

  1. Department of Gastroenterology, The First Medical Centre of Chinese PLA General Hospital, Beijing 100853, China; Nankai University School of Medicine, Nankai University, Tianjin 300071, China
    Department of Gastroenterology, The First Medical Centre of Chinese PLA General Hospital, Beijing 100853, China
  • Received:2023-07-11 Published:2023-11-15
  • Corresponding author: Enqiang Linghu
引用本文:

周晓晴, 宁波, 令狐恩强. 肠系膜脂膜炎临床诊治的研究进展[J/OL]. 中华胃肠内镜电子杂志, 2023, 10(04): 267-270.

Xiaoqing Zhou, Bo Ning, Enqiang Linghu. Research progress in diagnosis and treatment of mesenteric panniculitis[J/OL]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(04): 267-270.

肠系膜脂膜炎(MP)是累及肠系膜脂肪组织的一种慢性非特异性炎症,目前病因尚不明确,临床较为少见,本文从其病因及发病机制、临床表现、辅助检查、诊断与鉴别诊断、治疗和预后等方面进行系统综述,旨在为该病的临床诊疗提供更有力的参考。

Mesenteric panniculitis is a chronic non-specific inflammatory disease involving mesenteric adipose tissue. The etiology of the disease is still unclear and is relatively rare in clinical practice. The paper provides a systematic review of its etiology and pathogenesis, clinical manifestations, auxiliary examinations, diagnosis and differential diagnosis, treatment and prognosis, with the aim of providing a more powerful reference for the clinical treatment of the disease.

[1]
Jura SV.Mesenterile retrattile esclerosante[J]. Policlinica1924, 31: 575-581.
[2]
Ogden WW 2ndBradburn DMRives JD.Mesenteric panniculitis: review of 27 cases[J].Ann Surg1965161(6):864-875.
[3]
Eze Vivienne NHalligan Steve.Mesenteric panniculitis:A clinical conundrum[J].Br J Radiol202396(1142):20211369.
[4]
Alsuhaimi MAAlshowaiey RAAlsumaihi AS,et al.Mesenteric panniculitis various presentations and management:A single institute ten years,experience[J].Ann Surg202280:104203.
[5]
Hussein MRAbdelwahed SR.Mesenteric panniculitis:an update[J]. Expert Rev Gastroenterol Hepatol20159(1):67-78.
[6]
Rolff HCFallentin EWettergren A.Mesenteric panniculitis is a rare inflammation of the mesenteric adipose tissue[J].Ugeskr Laeger2011173 (20):1437-1438.
[7]
Mahafza WSManzalawi KAGharaibeh AA,et al.Diagnosis of mesenteric panniculitis in the multi-detector computed tomo-graphy era.Association with malignancy and surgical history[J].Saudi Med J201738(10):1013-1018.
[8]
刘斯,侯启圣,刘珵,等.41例肠系膜脂膜炎的临床特点分析[J].中国急救医学202141(5):404-406.
[9]
van Putte-katier Nvan Bommel EFElgersma OE,et al.Mesentericpanniculitis: prevalence, clinicoradiological presenta-tion and 5- year follow-up[J].Br J Radiol201487(1044):220140451.
[10]
Scheer FSpunar PWiggermann P,et al.Mesenteric panniculitis (MP) in CT-A predictor of malignancy[J].Rofo2016188(10):926-932.
[11]
Atacan HErkut MDeirmenci F,et al.A Single Tertiary Center 14-year Experience With Mesenteric Panniculitis in Turkey:A Retrospective Study of 716 Patients[J].Turk J Gastroenterol202334(2):140-147.
[12]
Buchwald PDiesing LDixon L,et al.Cohort study of mesenteric panniculitis and its relationship to malignancy[J].Br J Surg2016103(12):1727-1730.
[13]
álvarez García Málvarez Torices JCDíez Liébana MJ,et al. Thoracoabdominal manifestations of immunoglobulin G4-related disease[J].Radiologia (Engl Ed)202365(2):165-175.
[14]
Liu ZJiao YHe L,et al.A rare case report of immunoglobulin G4-related sclerosing mesenteritis and review of the literature[J]. Medicine (Baltimore)202099(41):e22579.
[15]
蒋青伟,王凤丹,王文泽,等.肠系膜脂膜炎12例临床特征分析[J].中华内科杂志201756(2):112-115.
[16]
Gunes SOAkturk YGuldogan ES,et al.Association between mesenteric panniculitis and non-neoplastic disorders[J].Clin Imag202179:219-224.
[17]
Schweistein HWeintraub YHornik-Lurie T,et al.Mesenteric panniculitis is associated with cardiovascular risk-factors:A case-control study[J].Dig Liver Dis202254(12):1657-1661.
[18]
Paudyal NShrestha BYadav D.Mesenteric panniculitis,a rare entity presenting as (sub)acute intestinal obstruction:a case report[J]. IJS:Short Reports20227(3):E56.
[19]
程相阵,张秀英.中国人肠系膜脂膜炎的临床特点分析344例[J].世界华人消化杂志201624(18):2908-2912.
[20]
张敏,李军.肠系膜脂膜炎一例[J].华西医学201631(3):596-597.
[21]
王凤丹,王萱,孙昊,等.肠系膜脂膜炎的影像特点[J].中华放射学杂志201347(4):371-373.
[22]
李浩,王飞,石岩,等.肠系膜脂膜炎的CT影像学特征及其与恶性肿瘤的关系[J].中国继续医学教育20179(23):56-58.
[23]
苏雅珍,郭乾育,马丹,等.CT诊断的肠系膜脂膜炎50例临床特点分析[J].中国实用内科杂志202040(2):146-149.
[24]
瞿俊晨,丁庆国,王文保,等.肠系膜脂膜炎的CT及MRI诊断[J].中国中西医结合影像学杂志201715(3):280-282.
[25]
宋晓坤,金鑫.肠系膜脂膜炎的超声识别[J].中国医药指南201715(9):13-14.
[26]
Sakata MToyokawa THamano R,et al.A rare finding from a colonoscopy and laparoscopy of a patient with mesenteric panniculitis mimicking cancerous peritonitis[J].Gastrointest Endosc, 202093(4):987-988.
[27]
Saito YHiramatsu KNosaka T,et al.A case of protein-losing enteropathy caused by sclerosing mesenteritis diagnosed with capsule endoscopy and double-balloon endoscopy[J].Clin J Gastroenterol201710(4):351-356.
[28]
杨柯,白少君,彭凤娥.肠系膜脂膜炎的临床症状、CT影像特点及病理分析[J].世界最新医学信息文摘201717(68):147-149.
[29]
Emory TSMonihan JMCarr NJ,et al.Sclerosing mesenteritis,mesenteric panniculitis and mesenteric lipodystrophy:a single entity?[J].Am J Surg Pathol199721(4):392-398.
[30]
Wagner CDachman AEhrenpreis ED.Mesenteric Panniculitis, Sclerosing Mesenteritis and Mesenteric Lipodystrophy:DescriptiveReview of a Rare Condition[J].Clin Colon Rectal Surg202235(4):342-348.
[31]
Mizuno SWakui MMachida Y,et al.Increased levels of prostaglandin E-major urinary metabolite(PGE-MUM) in active mesentericpanniculitis patients:A case report[J].Medicine201796(51):E9237.
[32]
Protin-Catteau LThiéfin GBarbe C,et al.Mesenteric panniculitis: review of consecutive abdominal MDCT examinations with amatched-pair analysis[J].Acta Radiol201657(1):1-7.
[33]
麦甘树,江汉联.常见引起肠系膜云雾状征象的影像分析[J].中国伤残医学201422(10):201-203.
[34]
周庆秋.恶性淋巴瘤累及腹腔、腹膜后淋巴结的多层螺旋CT表现特征[J].齐齐哈尔医学院学报201435(18):2710-2711.
[35]
程相阵.肠系膜脂肪肉瘤68例临床特点分析[J].世界最新医学信息文摘201717(86):20-24; 20-21,24.
[36]
Issa IBaydoun H.Mesenteric panniculitis:Various presentations and treatment regimens[J].World J Gastroenterol200915(30):3827-3830.
[37]
Gande SNguyen NNStead TS,et al.Sclerosing Mesenteritis Managed Conservatively With Prednisone[J].Cureus202315(2): E35419.
[38]
Bala ACoderre SPJohnson DR,et al.Treatment of sclerosing mesenteritis with corticosteroids and azathioprine[J].Can J Gastroenterol200115(8):533-535.
[39]
Akram SPardi DSSchaffner JA,et al.Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients[J].Clin Gastroenterol Hepatol20075(5):589-596.
[40]
Sahin AArtas HEroglu Y,et al.An Overlooked Potentially Treatable Disorder:Idiopathic Mesenteric Panniculitis[J].Med Princ Pract201726(6):567-572.
[41]
Cortés PGhoz HMMzaik O,et al.Colchicine as an Alternative First-Line Treatment of Sclerosing Mesenteritis:A Retrospective Study[J].Dig Dis Sci202267(6):2403-2412.
[42]
侯丁丁,王建方,秦春和,等.87例急性小肠梗阻手术时机及术式探讨[J].中国研究型医院20207(5):49-52.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 严华悦, 刘子祥, 周少波. 磷酸烯醇式丙酮酸羧激酶-1在恶性肿瘤中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 452-456.
[3] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[7] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[8] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[9] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[10] 石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[11] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[12] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[13] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[14] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?